Does the Waiting Period for Genetic Tests Affect the Prognosis in Chemotherapy-Treated de novo Metastatic Non-Small Cell Lung Cancer Patients without a Driver Mutation?

导出 LinkOut

翻译打印收藏纠错

第一作者： Serdar,Arici

第一单位： Department of Medical Oncology, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey, serdararici@hotmail.com.

作者： Serdar,Arici ^[1] ; Abdullah,Sakin ^[2] ; Ruhper,Cekin ^[3] ; Saban,Secmeler ^[3] ; Nurgül,Yasar ^[3] ; Sener,Cihan ^[3]

作者单位： Department of Medical Oncology, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey, serdararici@hotmail.com. ^[1] Department of Medical Oncology, Yuzuncu Yil University Medical School, Van, Turkey. ^[2] Department of Medical Oncology, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey. ^[3]

关键词 Driver mutations Duration between diagnosis and the start of first-line chemotherapy Non-small cell lung cancer

主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);无病生存(Disease-Free Survival);人类(Humans);肺肿瘤(Lung Neoplasms);突变(Mutation);预后(Prognosis)

DOI 10.1159/000511773

PMID 33242864

发布时间 2021-09-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Oncology research and treatment

2021年44卷1-2期

12-19页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Does the Waiting Period for Genetic Tests Affect the Prognosis in Chemotherapy-Treated de novo Metastatic Non-Small Cell Lung Cancer Patients without a Driver Mutation?

Oncology research and treatment

相似文献

Oncology research and treatment

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Does the Waiting Period for Genetic Tests Affect the Prognosis in Chemotherapy-Treated de novo Metastatic Non-Small Cell Lung Cancer Patients without a Driver Mutation?

Oncology research and treatment

相似文献

Oncology research and treatment

相关期刊

检索历史清除